PRCT compared with MESO: revenue, margins and what each company keeps, and the suppliers and customers both name

PRCTPROCEPT BioRobotics Corp

Mkt capRevenueRevenue

MESOMesoblast Ltd

Mkt capRevenueRevenue

Compare

PRCTPROCEPT BioRobotics Corp

MESOMesoblast Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PRCT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.8%▲+5.80%×0.35

Q1 FY26±19.3%▲+10.73%×0.55

Feb 26 '26±17.7%▼−15.12%×0.85

Nov 5 '25±18.7%▼−9.74%×0.52

MESO1 of 4 reports

Reportimpliedrealized× implied

Oct 16 '26—▼−4.80%—

= impliedPRCT realized, solidMESO realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

PRCTPROCEPT BioRobotics Corp

20.26▼−6.47%· post 20.26· delayed

Mkt cap$1.2BRevenue$98MQ3 FY26Revenue$308MFY25

MESOMesoblast Ltd

14.11▼−1.23%· post 14.11· delayed

After hoursNov 5 '26delayed

Mkt cap$3.7BRevenue—Revenue—

Compare

After hoursNov 5 '26delayed

PRCTPROCEPT BioRobotics Corp

MESOMesoblast Ltd

20.26▼−6.47%post 20.26delayed

Price

14.11▼−1.23%post 14.11delayed

$1.2B

Mkt cap

$3.7B

Q3 FY26$98M

Revenue

—

FY25$308M

Revenue

—

PRCT20.26▼−6.47%vsMESO14.11▼−1.23%After hoursNov 5 '26delayed